The five-year deal will see the parties work collaboratively to facilitate the manufacture of viral vector based vaccines

Updated Date: Fri, 29 May 2020 00:00:00 EDT

Scientists have taken another step forward on their quest to develop a viable drug based on teixobactin — […]

Godlee discusses the long road ahead after covid-19.1 Is this an opportunity to reimagine healthcare and forge a […]

A 34 year old man should have artificial feeding and hydration withdrawn because he would not have wanted […]

Left out of Warp Speed, Novavax scores $60M defense contract for COVID-19 shot esagonowsky Fri, 06/05/2020 – 11:06

What we eat can affect the outcome of chemotherapy – and likely many other medical treatments – because […]

FiercePharmaAsia—’Onshoring’ drug manufacturing; Takeda’s IBD pipeline cull; Legend’s $350M IPO aliu Fri, 06/05/2020 – 06:28

Lonza poaches Roche exec for CEO as Moderna COVID-19 collab speeds ahead aliu Fri, 06/05/2020 – 09:20

Inovio accuses manufacturing partner of hampering COVID-19 vaccine scale-up in lawsuit kblankenship Fri, 06/05/2020 – 09:26